Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 

(NEW) Prisma Health Pharmacy Residency Research Showcase 2023: Parts 1 & 2 (Home Study)


 
Target Audience:  Pharmacists
 
Fee:  $30 for whole program (or each part is $18 per)
        To register for either part 1 or part 2, click the drop down, and choose "Separate Pay".
 
Flyer:  Click Here
 
Speakers and Topics:
*  Please scroll down to view the presentation title and learning objectives for pharmacists
 
Credit Hours Available:  This program was pre-recorded.  Part 1 is accredited for 1.75 contact hours or 0.175 CEUS, video runtime is 1 hour 51 minutes long; Part 2 is accreded for 1.75 contact hours or 0.175 CEUs, video runtime is 1 hour 50 minutes long.
 
How to Earn Credit: Participants must 1) read the learning objectives and faculty disclosures, 2) listen to the video presentation and the interactivity, and 3) complete the evaluation form. To receive credit, you must provide your date of birth and NABP number. CE credit will be submitted to the NABP CE Monitor.
 
Required Computer Hardware/Software:
Please ensure the computer system you plan to use meets the following minimum requirements:
  • Operating System: Windows, Mac OS and Linux
  • Internet Browser: Internet Explorer 7.0 or higher; Mozilla Firefox 3.0 or higher; Google Chrome
  • Computer Speakers or headphones connected to your computer
  • Broadband Internet Connection: Cable, High-speed DSL or T1
  • Monitor Screen Resolution: 320x480 or higher
  • Media Viewing Requirements: Adobe Reader, Microsoft Power Point and HTML
Privacy and Confidentiality:  Information received by the University of South Carolina College of Pharmacy for continuing education (CE) programs will be maintained in a confidential and secure manner.  In order for continuing education credit to be submitted to the NABP CPE Monitor, personal information such as your NABP e-Profile ID and day and month of birth will be required along with your name and contact information. 
 
Provider Contact Information:  For questions regarding this continuing education activity, please contact our office at CE@cop.sc.edu or 803-777-9979.
 
Pharmacy Residency Research Showcase 2023:  Part 1
 
Evaluating the Addition of Atypical Antipsychotics to Continuous Infusion Propofol Therapy
Jake Crocker, PharmD; PGY1 Acute Care Pharmacy Resident
  • Review and quantify overall effectiveness of atypical antipsychotics on reduction in the amount of continuous infusion propofol utilized in the ICU
Incidence and Predictors of Acute Kidney Injury in Patients Receiving Hypertonic Saline in the Neuroscience Intensive Care Unit
Allyson Barnett, PharmD; PGY2 Critical Care Pharmacy Resident
  • Recognize potential contributors to acute kidney injury in patients receiving hypertonic saline
Evaluating the safety and effectiveness of long-term antibiotic suppression in patients with left ventricular assist devices
Kelsey D. Hamlin, PharmD; PGY1 Acute Care Pharmacy Resident
  • Describe the safety and effectiveness of chronic antibiotic suppression therapy for patients with a left ventricular assist device (LVAD)
Evaluating Dalbavancin Suppression Therapy in Patients at High Risk for Recurrent Infections
Michael K. Shaw, PharmD; PGY2 Infectious Diseases Pharmacy Resident
  • Determine the proportion of patients who experienced treatment-emergent adverse events (TEAE) while receiving dalbavancin suppressive therapy
Efficacy and Safety of SGLT2 Inhibitors in Patients with a Left Ventricular Assist Device 
Erik Preheim, PharmD; PGY1 Outpatient Focused Pharmacy Resident
  • Describe the safety and efficacy of SGLT2 inhibitors observed in patients supported by an LVAD
Treatment Outcome of Cabotegravir/Rilpivirine Long-Acting Injectable in Obese Patients
Y. Vivian Tsai, PharmD; Infectious Diseases Pharmacy Fellow
  • Discuss the clinical treatment outcomes of cabotegravir/rilpivirine long-acting injectable when administered every 8 weeks in obese patients
Impact of a Procalcitonin Guided Antibiotic Management Strategy in Pediatric Sickle Cell Patients with Fever
Hannah Robinson, PharmD; PGY2 Pediatric Pharmacy Resident
  • Identify the utility of procalcitonin’s on antibiotic duration of therapy in pediatric sickle cell patients with fever
 
Pharmacy Residency Research Showcase 2023:  Part 2
 
CSF Lactate as a Surrogate Marker for Infection in Patients with External Ventricular Drains and Ventriculoperitoneal Shunts
Abbie L. Blunier, PharmD; PGY1 Pharmacy Resident
  • Describe the role of cerebrospinal fluid (CSF) lactate concentration as an indicator of infection in patients who have an external ventricular drain (EVD) or ventriculoperitoneal (VP) shunt
Requirements for true access to SGLT2 inhibitors in a heart failure population
Lucy Rinehuls, PharmD; PGY1 Outpatient Focused Pharmacy Resident
  • Identify barriers to consistent, sustainable access of SGLT2 inhibitors for the treatment of heart failure
Impact of a Conservative Anticoagulation Protocol Following Gastrointestinal Bleeding in Patients with a HeartMate 3 LVAD
Ben Tabor, PharmD; PGY2 Cardiology Pharmacy Resident
  • Describe the impact of a conservative anticoagulation protocol following GIB on clinical outcomes in patients with a HM3 LVAD
Pharmacist Utilization of MRSA PCR Nasal Swabs for anti-MRSA Therapy Discontinuation
Tamia Jones, PharmD; PGY2 Internal Medicine Pharmacy Resident
  • Determine the difference in time to anti-MRSA therapy discontinuation for pneumonia based on pharmacist involvement
Evaluation of Longitudinal Advanced Pharmacy Practice Experience Block Programs on Student and Program Outcomes
Cassidy Kemp, PharmD; PGY2 HSPAL Pharmacy Resident
  • Describe current LAPPE programs including student and program outcomes
Impact of weight- or BSA-based hydrocortisone dosing on outcomes in patients with septic shock
Logan Boone, PharmD; PGY2 Critical Care Pharmacy Resident
  • Determine if varying hydrocortisone dosing strategies influence time to shock reversal
Evaluation of Safety of Tacrolimus in the Non-Transplant Hospital Setting
Scott Gourley, PharmD; PGY1 HSPAL Pharmacy Resident
  • Describe recent research pertaining to tacrolimus related medication errors and its importance of continuation in a non-transplant hospital

Fee

$30.00

CE Hours

3.50

CE Units

0.350

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

Prisma Health

Requirements for CE Credit

In order to receive credit for this home study program, participants must:
  1. Read the learning objectives and faculty disclosures
  2. Review the video presentation and engage in any suggested interactivity
  3. Complete the program evaluation form.
In order for credit to be transmitted to the NABP CPE Monitor, participants must provide their month and day of birth and NABP e-Profile ID number.  Registration with a proper disclosure of the NABP E-Id is a requirement for receiving Continuing Pharmacy Education.  To register with NABP CPE Monitor or look up your NABP E-profile ID, please click on the CPE Monitor logo below to be directed to their site.  Failure to follow this process within the required timeframe will result in loss of credit.  If you would like a paper statement of credit, you may print an individual statement or a transcript from your NABP e-profile.  
 
                                 

Please choose a Fee Type from the Drop Down Menu Below:
I am a
 

 

   

At the conclusion of this activity, the participant will be able to:
  1. Review and quantify overall effectiveness of atypical antipsychotics on reduction in the amount of continuous infusion propofol utilized in the ICU
  2. Recognize potential contributors to acute kidney injury in patients receiving hypertonic saline
  3. Describe the safety and effectiveness of chronic antibiotic suppression therapy for patients with a left ventricular assist device (LVAD)
  4. Determine the proportion of patients who experienced treatment-emergent adverse events (TEAE) while receiving dalbavancin suppressive therapy
  5. Describe the safety and efficacy of SGLT2 inhibitors observed in patients supported by an LVAD
  6. Discuss the clinical treatment outcomes of cabotegravir/rilpivirine long-acting injectable when administered every 8 weeks in obese patients
  7. Identify the utility of procalcitonin’s on antibiotic duration of therapy in pediatric sickle cell patients with fever

Speaker(s)/Author(s)

Allyson Barnett, PharmD
PGY2 Critical Care Pharmacy Resident, Prisma Health Richland Hospital

Erik Preheim, PharmD
PGY1 Ambulatory Care Pharmacy Resident, Prisma Health Richland

Hannah Robinson, PharmD
PGY2 Pediatric Pharmacy Resident, Prisma Health Children's Hospital - Midlands

Jake Crocker, PharmD
PGY2 Infectious Diseases Pharmacy Resident, Prisma Health Richland

Kelsey Hamlin, PharmD
PGY1 Pharmacy Resident, Prisma Health Midlands

Michael K. Shaw, PharmD
PGY2 Infectious Diseases Pharmacy Resident, Prisma Health Richland

Y. Vivian Tsai, PharmD
Infectious Diseases Clinical Pharmacy Fellow, Prisma Health Richland - University of South Carolina

Activity Number

0062-9999-23-122-H01-P

Release Date: Jul 3, 2023
Credit Expiration Date: Jul 3, 2026

CE Hours

1.75

Location

Prisma Health Richland
   

   

At the completion of this activity, the participant will be able to:
  1. Describe the role of cerebrospinal fluid (CSF) lactate concentration as an indicator of infection in patients who have an external ventricular drain (EVD) or ventriculoperitoneal (VP) shunt
  2. Identify barriers to consistent, sustainable access of SGLT2 inhibitors for the treatment of heart failure
  3. Describe the impact of a conservative anticoagulation protocol following GIB on clinical outcomes in patients with a HM3 LVAD
  4. Determine the difference in time to anti-MRSA therapy discontinuation for pneumonia based on pharmacist involvement
  5. Describe current LAPPE programs including student and program outcomes
  6. Determine if varying hydrocortisone dosing strategies influence time to shock reversal
  7. Describe recent research pertaining to tacrolimus related medication errors and its importance of continuation in a non-transplant hospital

Speaker(s)/Author(s)

Abbie L. Blunier, PharmD
PGY2 Infectious Diseases Pharmacy Resident, Prisma Health Richland

Benjamin Tabor, PharmD
PGY2 Cardiology Pharmacy Resident, Prisma Health Richland

Cassidy H. Kemp, PharmD
PGY2 Health System Pharmacy Administration and Leadership (HSPAL) Resident, Prisma Health Richland Hospital

Logan Boone, PharmD
PGY2 Critical Care Pharmacy Resident, Prisma Health Richland Hospital

Lucy Rinehuls, PharmD
PGY1 Ambulatory Care Pharmacy Resident, Prisma Health

Scott Gourley, PharmD, MBA
PGY2 HSPAL Pharmacy Resident, Prisma Health Richland

Tamia Jones, PharmD
PGY2 Internal Medicine Pharmacy Resident, Prisma Health

Activity Number

0062-9999-23-123-H01-P

Release Date: Jul 3, 2023
Credit Expiration Date: Jul 3, 2026

CE Hours

1.75